The pharmacokinetics of hemoglobin-based oxygen carrier hemoglobin glutamer-200 bovine in the horse

Anesthesia and Analgesia

Volumn 100, Issue 6, 2005, Pages 1570-1575

  Soma, Lawrence R ^a   Uboh, Cornelius E ^a,b   Guan, Fuyu ^a   Luo, Yi ^a   Moate, Peter J ^a   Boston, Raymond C ^a   Driessen, Bernd ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN GLUTAMER 200; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CHILD; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HEMOGLOBIN DETERMINATION; HORSE; HUMAN; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL;

ALGORITHMS; ANIMALS; AREA UNDER CURVE; BLOOD SUBSTITUTES; CATTLE; FEMALE; HALF-LIFE; HEMOGLOBINS; HORSES; INFUSIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; OXYGEN;

EID: 19044370587     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000154081.38466.09     Document Type: Article

References (23)

1. Winslow RM. New transfusion strategies: red cell substitutes. Annu Rev Med 1999;50:337-53.
2. Driessen B, Jahr JS, Lurie F, et al. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study. Crit Care Med 2003;31:1771-9.
3. Schumacher YO, Schmid A, Dinkelmann S, et al. Artificial oxygen carriers: the new doping threat in endurance sport? Int J Sports Med 2001;22:566-71.
4. Haney CR, Buehler PW, Gulati A. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. Adv Drug Deliv Rev 2000;40:153-69.
5. Guan F, Uboh CE, Soma LR, et al. Confirmation and quantification of hemoglobin-based, oxygen carriers in equine and human plasma by liquid chromatography tandem mass spectrometry. Anal Chem 2004;76:5127-35.
6. Guan F, Uboh CE, Soma LR, et al. Unique tryptic peptides specific for bovine and human hemoglobin in the detection and confirmation of hemoglobin-based oxygen carrier. Anal Chem 2004;76:5118-26.
7. Stefanovski D, Moate PJ, Boston C. WinSAAM: a windows based compartmental modeling system. J Metab 2003;52:1153-66.
8. Varlet-Marie E, Ashenden M, Lasne F, et al. Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC. Clin Chem 2004;50:723-31.
9. Thevis M, Ogorzalek Loo RR, Loo JA, Schanzer W. Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. Anal Chem 2003;75:2955-61.
10. Hsia JC, Song DL, Er SS, et al. Pharmacokinetic studies in the rat on a o-raffinose polymerized human hemoglobin. Biomater Artif Cells Immobilization Biotechnol 1992;20:587-95.
11. Hughes GS Jr, Antal EJ, Locker PK, et al. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996;24:756-64.
12. Keipert PE, Gomez CL, Gonzales A, et al. The role of the kidneys in the excretion of chemically modified hemoglobins. Biomater Artif Cells Immobilization Biotechnol 1992;20:737-45.
13. Malchesky PS, Takahashi T, Iwasaki K, et al. Conjugated human hemoglobin as a physiological oxygen carrier: pyridoxalated hemoglobin polyoxyethylene conjugate (PHP). Int J Artif Organs 1990;13:442-50.
14. Palaparthy R, Kastrissios H, Gulati A. Pharmacokinetics of diaspirin cross-linked haemoglobin in a rat model of hepatic cirrhosis. J Pharm Pharmacol 2001;53:179-85.
15. Vandegriff KD, Malavalli A, Wooldridge J, et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 2003;43:509-16.
16. Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 1994;74:163-219.
17. Conhaim RL, Cooler SD, McGrath AM, et al. Filtration of diaspirin crosslinked hemoglobin into lung and soft tissue lymph. Am J Respir Crit Care Med 1998;158:1204-12.
18. Conhaim RL, Rodenkirch LA, Watson KE, Harms BA. Acellular hemoglobin solution enters compressed lung capillaries more readily than red blood cells. J Appl Physiol 2000;89:1198-204.
19. Matheson B, Kwansa HE, Bucci E, et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 2002;93:1479-86.
20. Keipert PE, Gomez CL, Gonzales A, et al. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994;123:701-11.
21. Naylor JR, Bayly WM, Schott HC 2nd, et al. Equine plasma and blood volumes decrease with dehydration but subsequently increase with exercise. J Appl Physiol 1993;75:1002-8.
22. Muir WW, Kohn CW, Sams R. Effects of furosemide on plasma volume and extracellular fluid volume in horses. Am J Vet Res 1978;39:1688-91.
23. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-68.